Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 636

1.

Progressive Encephalomyelitis with Rigidity and Myoclonus Resolving after Thymectomy with Subsequent Anasarca: An Autopsy Case.

Ozaki K, Ohkubo T, Yamada T, Yoshioka K, Ichijo M, Majima T, Kudo S, Akashi T, Honda K, Ito E, Watanabe M, Sekine M, Hamagaki M, Eishi Y, Sanjo N, Ishibashi S, Mizusawa H, Yokota T.

Intern Med. 2018 Jul 6. doi: 10.2169/internalmedicine.1238-18. [Epub ahead of print]

2.

Tandem internal models execute motor learning in the cerebellum.

Honda T, Nagao S, Hashimoto Y, Ishikawa K, Yokota T, Mizusawa H, Ito M.

Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7428-7433. doi: 10.1073/pnas.1716489115. Epub 2018 Jun 25.

3.

Iatrogenic Creutzfeldt-Jakob disease.

Kobayashi A, Kitamoto T, Mizusawa H.

Handb Clin Neurol. 2018;153:207-218. doi: 10.1016/B978-0-444-63945-5.00012-X.

PMID:
29887137
4.

Analysis of risk factors for mild cognitive impairment based on word list memory test results and questionnaire responses in healthy Japanese individuals registered in an online database.

Ogawa M, Sone D, Maruo K, Shimada H, Suzuki K, Watanabe H, Matsuda H, Mizusawa H.

PLoS One. 2018 May 17;13(5):e0197466. doi: 10.1371/journal.pone.0197466. eCollection 2018.

5.

A diagnostic decision tree for adult cerebellar ataxia based on pontine magnetic resonance imaging.

Higashi M, Ozaki K, Hattori T, Ishii T, Soga K, Sato N, Tomita M, Mizusawa H, Ishikawa K, Yokota T.

J Neurol Sci. 2018 Apr 15;387:187-195. doi: 10.1016/j.jns.2018.02.022. Epub 2018 Feb 12.

PMID:
29571861
6.

Update: Dura Mater Graft-Associated Creutzfeldt-Jakob Disease - Japan, 1975-2017.

Ae R, Hamaguchi T, Nakamura Y, Yamada M, Tsukamoto T, Mizusawa H, Belay ED, Schonberger LB.

MMWR Morb Mortal Wkly Rep. 2018 Mar 9;67(9):274-278. doi: 10.15585/mmwr.mm6709a3.

7.

Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Zesiewicz TA, Wilmot G, Kuo SH, Perlman S, Greenstein PE, Ying SH, Ashizawa T, Subramony SH, Schmahmann JD, Figueroa KP, Mizusawa H, Schöls L, Shaw JD, Dubinsky RM, Armstrong MJ, Gronseth GS, Sullivan KL.

Neurology. 2018 Mar 6;90(10):464-471. doi: 10.1212/WNL.0000000000005055. Epub 2018 Feb 9.

PMID:
29440566
8.

Biochemical features of genetic Creutzfeldt-Jakob disease with valine-to-isoleucine substitution at codon 180 on the prion protein gene.

Ito Y, Sanjo N, Hizume M, Kobayashi A, Ohgami T, Satoh K, Hamaguchi T, Yamada M, Kitamoto T, Mizusawa H, Yokota T.

Biochem Biophys Res Commun. 2018 Feb 19;496(4):1055-1061. doi: 10.1016/j.bbrc.2018.01.119. Epub 2018 Jan 31.

PMID:
29382530
9.

Idiopathic cerebellar ataxia (IDCA): Diagnostic criteria and clinical analyses of 63 Japanese patients.

Yoshida K, Kuwabara S, Nakamura K, Abe R, Matsushima A, Beppu M, Yamanaka Y, Takahashi Y, Sasaki H, Mizusawa H; Research Group on Ataxic Disorders.

J Neurol Sci. 2018 Jan 15;384:30-35. doi: 10.1016/j.jns.2017.11.008. Epub 2017 Nov 7.

10.

Sequence configuration of spinocerebellar ataxia type 8 repeat expansions in a Japanese cohort of 797 ataxia subjects.

Hu Y, Hashimoto Y, Ishii T, Rayle M, Soga K, Sato N, Okita M, Higashi M, Ozaki K, Mizusawa H, Ishikawa K, Yokota T.

J Neurol Sci. 2017 Nov 15;382:87-90. doi: 10.1016/j.jns.2017.08.3256. Epub 2017 Aug 31.

PMID:
29111027
11.

The professional practice and training of neurology in the Asian and Oceanian Region: A cross-sectional survey by the Asian and Oceanian Association of Neurology (AOAN).

Roxas A Jr, Mehndiratta MM, Bornstein N, Macdonell R, Lim KS, Ng PW, Dashzeveg S, Mizusawa H, Esmatullah H, Wu SL, Chen C, Kurniawan M, Rha JH, Wasay M, Poungvarin N, Gunatilake S, Thang NH.

J Neurol Sci. 2017 Nov 15;382:108-115. doi: 10.1016/j.jns.2017.09.022. Epub 2017 Sep 20.

PMID:
29111001
12.

Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain.

Anraku Y, Kuwahara H, Fukusato Y, Mizoguchi A, Ishii T, Nitta K, Matsumoto Y, Toh K, Miyata K, Uchida S, Nishina K, Osada K, Itaka K, Nishiyama N, Mizusawa H, Yamasoba T, Yokota T, Kataoka K.

Nat Commun. 2017 Oct 17;8(1):1001. doi: 10.1038/s41467-017-00952-3.

13.

Re-evaluation of soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disorders.

Araki W, Hattori K, Kanemaru K, Yokoi Y, Omachi Y, Takano H, Sakata M, Yoshida S, Tsukamoto T, Murata M, Saito Y, Kunugi H, Goto YI, Nagaoka U, Nagao M, Komori T, Arima K, Ishii K, Murayama S, Matsuda H, Tachimori H, Araki YM, Mizusawa H.

Biomark Res. 2017 Sep 22;5:28. doi: 10.1186/s40364-017-0108-5. eCollection 2017.

14.

Subacute Supranuclear Palsy in anti-Hu Paraneoplastic Encephalitis.

Ohyagi M, Ishibashi S, Ohkubo T, Kobayashi Z, Mizusawa H, Yokota T, Emoto H, Kiyosawa M.

Can J Neurol Sci. 2017 Jul;44(4):444-446. doi: 10.1017/cjn.2016.430. No abstract available.

PMID:
28767032
15.

Long-term Effects of Intravenous Cyclophosphamide in Combination with Mesna Provided Intravenously and via Bladder Perfusion in a Patient with Severe Multifocal Motor Neuropathy.

Iwasawa E, Ohkubo T, Kanouchi T, Kanda T, Mizusawa H, Yokota T.

Intern Med. 2017;56(14):1893-1896. doi: 10.2169/internalmedicine.56.8157. Epub 2017 Jul 15.

16.

Questionnaire survey on the process of specialty training in neurology in Japan.

Sonoo M, Nishiyama K, Ando T, Shindo K, Kanda T, Aoki M, Kamei S, Kikuchi S, Kusunoki S, Suzuki N, Sobue G, Nakashima K, Hara H, Hirata K, Mizusawa H, Murai H, Murata M, Mochizuki H, Takahashi R, Kira JI.

Rinsho Shinkeigaku. 2017 Jul 29;57(7):402-410. doi: 10.5692/clinicalneurol.cn-001061. Epub 2017 Jul 21. Japanese.

PMID:
28637938
17.

Alternative splicing in the C-terminal tail of Cav2.1 is essential for preventing a neurological disease in mice.

Aikawa T, Watanabe T, Miyazaki T, Mikuni T, Wakamori M, Sakurai M, Aizawa H, Ishizu N, Watanabe M, Kano M, Mizusawa H, Watase K.

Hum Mol Genet. 2017 Aug 15;26(16):3094-3104. doi: 10.1093/hmg/ddx193.

PMID:
28510727
18.

Regulatory Role of RNA Chaperone TDP-43 for RNA Misfolding and Repeat-Associated Translation in SCA31.

Ishiguro T, Sato N, Ueyama M, Fujikake N, Sellier C, Kanegami A, Tokuda E, Zamiri B, Gall-Duncan T, Mirceta M, Furukawa Y, Yokota T, Wada K, Taylor JP, Pearson CE, Charlet-Berguerand N, Mizusawa H, Nagai Y, Ishikawa K.

Neuron. 2017 Apr 5;94(1):108-124.e7. doi: 10.1016/j.neuron.2017.02.046. Epub 2017 Mar 23.

19.

Structural connectivity in spatial attention network: reconstruction from left hemispatial neglect.

Hattori T, Ito K, Nakazawa C, Numasawa Y, Watanabe M, Aoki S, Mizusawa H, Ishiai S, Yokota T.

Brain Imaging Behav. 2018 Apr;12(2):309-323. doi: 10.1007/s11682-017-9698-7.

PMID:
28290071
20.

Depressive disorder may be associated with raphe nuclei lesions in patients with brainstem infarction.

Numasawa Y, Hattori T, Ishiai S, Kobayashi Z, Kamata T, Kotera M, Ishibashi S, Sanjo N, Mizusawa H, Yokota T.

J Affect Disord. 2017 Apr 15;213:191-198. doi: 10.1016/j.jad.2017.02.005. Epub 2017 Feb 7.

PMID:
28278447
21.

Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice.

Ishizu N, Yui D, Hebisawa A, Aizawa H, Cui W, Fujita Y, Hashimoto K, Ajioka I, Mizusawa H, Yokota T, Watase K.

Hum Mol Genet. 2016 Oct 15;25(20):4507-4517. doi: 10.1093/hmg/ddw279.

PMID:
28173004
22.

Gene dosage effect in spinocerebellar ataxia type 6 homozygotes: A clinical and neuropathological study.

Soga K, Ishikawa K, Furuya T, Iida T, Yamada T, Ando N, Ota K, Kanno-Okada H, Tanaka S, Shintaku M, Eishi Y, Mizusawa H, Yokota T.

J Neurol Sci. 2017 Feb 15;373:321-328. doi: 10.1016/j.jns.2016.12.051. Epub 2016 Dec 27.

PMID:
28131213
23.

Thalamic involvement determined using VSRAD advance on MRI and easy Z-score analysis of 99mTc-ECD-SPECT in Gerstmann-Sträussler-Scheinker syndrome with P102L mutation.

Sugiyama A, Sato N, Kimura Y, Maekawa T, Wakasugi N, Sone D, Enokizono M, Takahashi Y, Murata M, Mizusawa H, Matsuda H.

J Neurol Sci. 2017 Feb 15;373:27-30. doi: 10.1016/j.jns.2016.12.021. Epub 2016 Dec 15.

PMID:
28131204
24.

Processes of anticipatory postural adjustment and step movement of gait initiation.

Mizusawa H, Jono Y, Iwata Y, Kinoshita A, Hiraoka K.

Hum Mov Sci. 2017 Apr;52:1-16. doi: 10.1016/j.humov.2017.01.003. Epub 2017 Jan 13.

PMID:
28088660
25.

Interhemispheric Inhibition Induced by Transcranial Magnetic Stimulation Over Primary Sensory Cortex.

Iwata Y, Jono Y, Mizusawa H, Kinoshita A, Hiraoka K.

Front Hum Neurosci. 2016 Aug 31;10:438. doi: 10.3389/fnhum.2016.00438. eCollection 2016.

26.

PRION 2016 Tokyo Declaration.

Mizusawa H, Kuwata K.

Prion. 2016 Jul 3;10(4):265-6. doi: 10.1080/19336896.2016.1220242. No abstract available.

27.

[Bilateral Testicular Tumor after Bilateral Orchiopexy : A Case Report].

Saito T, Mizusawa H, Hara H, Domen T.

Hinyokika Kiyo. 2016 May;62(5):279-81. Japanese.

PMID:
27320122
28.

Significant association of cadaveric dura mater grafting with subpial Aβ deposition and meningeal amyloid angiopathy.

Hamaguchi T, Taniguchi Y, Sakai K, Kitamoto T, Takao M, Murayama S, Iwasaki Y, Yoshida M, Shimizu H, Kakita A, Takahashi H, Suzuki H, Naiki H, Sanjo N, Mizusawa H, Yamada M.

Acta Neuropathol. 2016 Aug;132(2):313-5. doi: 10.1007/s00401-016-1588-3. Epub 2016 Jun 17. No abstract available.

PMID:
27314593
29.

ORANGE's challenge: developing wide-ranging dementia research in Japan.

Saji N, Sakurai T, Suzuki K, Mizusawa H, Toba K; ORANGE investigators.

Lancet Neurol. 2016 Jun;15(7):661-662. doi: 10.1016/S1474-4422(16)30009-6. Epub 2016 May 9. No abstract available.

PMID:
27302232
30.

Progressive Multifocal Leukoencephalopathy with Balanced CD4/CD8 T-Cell Infiltration and Good Response to Mefloquine Treatment.

Sanjo N, Kina S, Shishido-Hara Y, Nose Y, Ishibashi S, Fukuda T, Maehara T, Eishi Y, Mizusawa H, Yokota T.

Intern Med. 2016;55(12):1631-5. doi: 10.2169/internalmedicine.55.6051. Epub 2016 Jun 15.

31.
32.

Specific clinical signs and symptoms are predictive of clinical course in sporadic Creutzfeldt-Jakob disease.

Nakatani E, Kanatani Y, Kaneda H, Nagai Y, Teramukai S, Nishimura T, Zhou B, Kojima S, Kono H, Fukushima M, Kitamoto T, Mizusawa H.

Eur J Neurol. 2016 Sep;23(9):1455-62. doi: 10.1111/ene.13057. Epub 2016 May 24.

33.

Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases.

Yokote H, Mizusawa H.

Neural Regen Res. 2016 Mar;11(3):410-1. doi: 10.4103/1673-5374.179048. No abstract available.

34.

Supplement Note.

Mizusawa H.

Prion. 2016;10 Suppl 1:S1. doi: 10.1080/19336896.2016.1173501. No abstract available.

PMID:
27088806
35.

Prevalence of Autoantibodies and the Efficacy of Immunotherapy for Autoimmune Cerebellar Ataxia.

Nanri K, Okuma M, Sato S, Yoneda M, Taguchi T, Mitoma H, Yamada J, Unezaki S, Nagatani T, Otsubo S, Sugawara M, Tanaka N, Mizusawa H.

Intern Med. 2016;55(5):449-54. doi: 10.2169/internalmedicine.55.5156. Epub 2016 Mar 1.

36.

Quantifying prion disease penetrance using large population control cohorts.

Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, McLean CY, Tung JY, Yu LP, Gambetti P, Blevins J, Zhang S, Cohen Y, Chen W, Yamada M, Hamaguchi T, Sanjo N, Mizusawa H, Nakamura Y, Kitamoto T, Collins SJ, Boyd A, Will RG, Knight R, Ponto C, Zerr I, Kraus TF, Eigenbrod S, Giese A, Calero M, de Pedro-Cuesta J, Haïk S, Laplanche JL, Bouaziz-Amar E, Brandel JP, Capellari S, Parchi P, Poleggi A, Ladogana A, O'Donnell-Luria AH, Karczewski KJ, Marshall JL, Boehnke M, Laakso M, Mohlke KL, Kähler A, Chambert K, McCarroll S, Sullivan PF, Hultman CM, Purcell SM, Sklar P, van der Lee SJ, Rozemuller A, Jansen C, Hofman A, Kraaij R, van Rooij JG, Ikram MA, Uitterlinden AG, van Duijn CM; Exome Aggregation Consortium (ExAC), Daly MJ, MacArthur DG.

Sci Transl Med. 2016 Jan 20;8(322):322ra9. doi: 10.1126/scitranslmed.aad5169.

37.

Enhanced Phospholipase A2 Group 3 Expression by Oxidative Stress Decreases the Insulin-Degrading Enzyme.

Yui D, Nishida Y, Nishina T, Mogushi K, Tajiri M, Ishibashi S, Ajioka I, Ishikawa K, Mizusawa H, Murayama S, Yokota T.

PLoS One. 2015 Dec 4;10(12):e0143518. doi: 10.1371/journal.pone.0143518. eCollection 2015.

38.

Enteral siRNA delivery technique for therapeutic gene silencing in the liver via the lymphatic route.

Murakami M, Nishina K, Watanabe C, Yoshida-Tanaka K, Piao W, Kuwahara H, Horikiri Y, Miyata K, Nishiyama N, Kataoka K, Yoshida M, Mizusawa H, Yokota T.

Sci Rep. 2015 Nov 23;5:17035. doi: 10.1038/srep17035.

39.

Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica.

Yamasaki R, Matsushita T, Fukazawa T, Yokoyama K, Fujihara K, Ogino M, Yokota T, Miyamoto K, Niino M, Nomura K, Tomioka R, Tanaka M, Kawachi I, Ohashi T, Kaida K, Matsui M, Nakatsuji Y, Ochi H, Fukaura H, Kanda T, Nagaishi A, Togo K, Mizusawa H, Murai H, Kira J.

Mult Scler. 2016 Sep;22(10):1337-48. doi: 10.1177/1352458515617248. Epub 2015 Nov 12.

PMID:
26564994
40.

Clinical, biochemical and molecular investigation of adult-onset glutaric acidemia type II: Characteristics in comparison with pediatric cases.

Yamada K, Kobayashi H, Bo R, Takahashi T, Purevsuren J, Hasegawa Y, Taketani T, Fukuda S, Ohkubo T, Yokota T, Watanabe M, Tsunemi T, Mizusawa H, Takuma H, Shioya A, Ishii A, Tamaoka A, Shigematsu Y, Sugie H, Yamaguchi S.

Brain Dev. 2016 Mar;38(3):293-301. doi: 10.1016/j.braindev.2015.08.011. Epub 2015 Sep 26.

PMID:
26403312
41.

Sphingosine-1-Phosphate Receptor-1 Selective Agonist Enhances Collateral Growth and Protects against Subsequent Stroke.

Ichijo M, Ishibashi S, Li F, Yui D, Miki K, Mizusawa H, Yokota T.

PLoS One. 2015 Sep 14;10(9):e0138029. doi: 10.1371/journal.pone.0138029. eCollection 2015.

42.

DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing.

Nishina K, Piao W, Yoshida-Tanaka K, Sujino Y, Nishina T, Yamamoto T, Nitta K, Yoshioka K, Kuwahara H, Yasuhara H, Baba T, Ono F, Miyata K, Miyake K, Seth PP, Low A, Yoshida M, Bennett CF, Kataoka K, Mizusawa H, Obika S, Yokota T.

Nat Commun. 2015 Aug 10;6:7969. doi: 10.1038/ncomms8969.

43.

Significance of Development and Reversion of Collaterals on MRI in Early Neurologic Improvement and Long-Term Functional Outcome after Intravenous Thrombolysis for Ischemic Stroke.

Ichijo M, Iwasawa E, Numasawa Y, Miki K, Ishibashi S, Tomita M, Tomimitsu H, Kamata T, Fujigasaki H, Shintani S, Mizusawa H.

AJNR Am J Neuroradiol. 2015 Oct;36(10):1839-45. doi: 10.3174/ajnr.A4384. Epub 2015 Jul 23.

44.

A Score for Predicting Paroxysmal Atrial Fibrillation in Acute Stroke Patients: iPAB Score.

Yoshioka K, Watanabe K, Zeniya S, Ito Y, Hizume M, Kanazawa T, Tomita M, Ishibashi S, Miake H, Tanaka H, Yokota T, Mizusawa H.

J Stroke Cerebrovasc Dis. 2015 Oct;24(10):2263-9. doi: 10.1016/j.jstrokecerebrovasdis.2015.06.019. Epub 2015 Jul 17.

PMID:
26190307
45.

Loss of MyD88 alters neuroinflammatory response and attenuates early Purkinje cell loss in a spinocerebellar ataxia type 6 mouse model.

Aikawa T, Mogushi K, Iijima-Tsutsui K, Ishikawa K, Sakurai M, Tanaka H, Mizusawa H, Watase K.

Hum Mol Genet. 2015 Sep 1;24(17):4780-91. doi: 10.1093/hmg/ddv202. Epub 2015 Jun 1.

46.

When should we test patients with familial ataxias for SCA31? A misdiagnosed condition outside Japan?

Pedroso JL, Abrahao A, Ishikawa K, Raskin S, de Souza PV, de Rezende Pinto WB, Braga-Neto P, de Albuquerque MV, Mizusawa H, Barsottini OG.

J Neurol Sci. 2015 Aug 15;355(1-2):206-8. doi: 10.1016/j.jns.2015.05.016. Epub 2015 May 21. No abstract available.

PMID:
26033715
47.

The influence of PRNP polymorphisms on human prion disease susceptibility: an update.

Kobayashi A, Teruya K, Matsuura Y, Shirai T, Nakamura Y, Yamada M, Mizusawa H, Mohri S, Kitamoto T.

Acta Neuropathol. 2015 Aug;130(2):159-70. doi: 10.1007/s00401-015-1447-7. Epub 2015 May 29. Review.

PMID:
26022925
48.

A Novel Mutation in ELOVL4 Leading to Spinocerebellar Ataxia (SCA) With the Hot Cross Bun Sign but Lacking Erythrokeratodermia: A Broadened Spectrum of SCA34.

Ozaki K, Doi H, Mitsui J, Sato N, Iikuni Y, Majima T, Yamane K, Irioka T, Ishiura H, Doi K, Morishita S, Higashi M, Sekiguchi T, Koyama K, Ueda N, Miura Y, Miyatake S, Matsumoto N, Yokota T, Tanaka F, Tsuji S, Mizusawa H, Ishikawa K.

JAMA Neurol. 2015 Jul;72(7):797-805. doi: 10.1001/jamaneurol.2015.0610.

PMID:
26010696
49.

Clinical characteristics of combined cases of spinocerebellar ataxia types 6 and 31.

Ohmori H, Hara A, Ishikawa K, Mizusawa H, Ando Y.

J Neurogenet. 2015;29(2-3):80-4. doi: 10.3109/01677063.2015.1054992. Epub 2015 Jul 13.

PMID:
26004545
50.

Variants associated with Gaucher disease in multiple system atrophy.

Mitsui J, Matsukawa T, Sasaki H, Yabe I, Matsushima M, Dürr A, Brice A, Takashima H, Kikuchi A, Aoki M, Ishiura H, Yasuda T, Date H, Ahsan B, Iwata A, Goto J, Ichikawa Y, Nakahara Y, Momose Y, Takahashi Y, Hara K, Kakita A, Yamada M, Takahashi H, Onodera O, Nishizawa M, Watanabe H, Ito M, Sobue G, Ishikawa K, Mizusawa H, Kanai K, Hattori T, Kuwabara S, Arai K, Koyano S, Kuroiwa Y, Hasegawa K, Yuasa T, Yasui K, Nakashima K, Ito H, Izumi Y, Kaji R, Kato T, Kusunoki S, Osaki Y, Horiuchi M, Kondo T, Murayama S, Hattori N, Yamamoto M, Murata M, Satake W, Toda T, Filla A, Klockgether T, Wüllner U, Nicholson G, Gilman S, Tanner CM, Kukull WA, Stern MB, Lee VM, Trojanowski JQ, Masliah E, Low PA, Sandroni P, Ozelius LJ, Foroud T, Tsuji S.

Ann Clin Transl Neurol. 2015 Apr;2(4):417-26. doi: 10.1002/acn3.185. Epub 2015 Feb 28.

Supplemental Content

Loading ...
Support Center